Arteris, Inc. SEC Filings

Arteris, Inc. (AIP) reporting person Bayview Legacy, LLC (managed by K. Charles Janac) sold 50,000 shares of common stock on 10/08/2025 under a pre-existing 10b5-1 trading plan. The weighted average sale price was $13.0742 (individual trades ranged from $13.00 to $13.20). After the sale, Bayview Legacy, LLC is reported to beneficially own 9,689,071 shares indirectly through the manager relationship. The filing notes that Janac separately filed an individual Form 4 to report the same transaction and confirms he is deemed to have voting and dispositive power over the shares held by Bayview Legacy, LLC.

Insider sale under 10b5-1 plan. The filing shows that Nicholas B. Hawkins, Vice President and Chief Financial Officer of Arteris, Inc. (AIP), sold 6,421 shares of common stock on 10/07/2025 at a weighted average price of $13.2073 per share. The report states the sales were executed under a 10b5-1 trading plan adopted on 06/04/2025. After the transactions, Hawkins beneficially owned 93,590 shares. The filer notes the sale prices ranged from $12.85 to $14.11 and offers to disclose per‑price quantities on request.

Arteris, Inc. director, president and CEO Janac K. Charles reported sales under a pre-established 10b5-1 plan. On 10/06/2025 the reporting person sold 5,755 shares at a listed price of $14 and sold an additional 100,000 shares at a weighted average price of $13.1045 (individual trades ranged from $12.50 to $13.85). After these transactions, direct beneficial ownership is reported as 161,759 shares and indirect ownership through entities is 9,739,071 shares. The filing notes the sales were executed pursuant to a trading plan adopted on 03/05/2025.

Arteris, Inc. insider filing reports that Bayview Legacy, LLC, an entity managed by K. Charles Janac, sold 100,000 shares of Arteris common stock on 10/06/2025 under a 10b5-1 trading plan. The sales were executed in multiple transactions at weighted-average price $13.1045, with trade prices ranging from $12.50 to $13.85. After the disposition, Bayview Legacy, LLC is reported to beneficially own 9,739,071 shares, and Janac is deemed to have voting and dispositive power as the manager. Janac also filed a separate Form 4 reporting the same sale in his individual capacity.

Arteris, Inc. director Antonio J. Viana reported insider sales on 10/06/2025. The filing shows a sale of 11,841 shares of common stock at a price of $14 and an additional disposal of 20,840 common shares. After these transactions the reporting person is listed as beneficially owning 184,620 shares indirectly through the Viana Family Trust. The sales were made under a pre-existing Rule 10b5-1 trading plan that the reporting person adopted on 06/10/2025, and the Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing presents routine, planned insider disposals rather than unscheduled or ad-hoc trades.

Arteris, Inc. (AIP) submitted a Rule 144 notice proposing the sale of 50,000 common shares through Morgan Stanley Smith Barney LLC for an aggregate market value of $647,500. The notice lists the company's total outstanding shares as 42,649,917 and an approximate sale date of 10/08/2025. The shares were originally acquired from the issuer in a private transaction on 11/05/2013 and were paid for in cash. The filing also discloses multiple recent sales by related parties and 10b5-1 plans in the past three months, including transactions dated 08/05/2025, 09/02/2025, and 10/06/2025, with amounts ranging up to $1,310,450.00 in gross proceeds for a single sale.

Arteris, Inc. filing a Form 144 notifies a proposed sale of 6,421 common shares (acquired as restricted stock units) with an aggregate market value of $87,197.18, through Morgan Stanley Smith Barney LLC on or about 10/07/2025. The RSUs were recorded as acquired on 10/01/2025 and the filing lists previous sales by the same person totaling 30,538 shares during the prior three months, generating gross proceeds of $336,546.61. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 sales plans used for several prior transactions.

Insider sale summary: A Form 4 shows that Paul L. Alpern, Vice President and General Counsel of Arteris, Inc. (AIP), sold a total of 7,627 shares of common stock in two days, 10/02/2025 and 10/03/2025, to satisfy tax obligations arising from the release of restricted stock units and under a previously adopted trading plan. The reported weighted average sale prices ranged from $10.81 to $11.30 with the weighted averages disclosed as $10.9208 and $11.082.

After these dispositions, the reporting person beneficially owned 65,960 shares directly. One tranche of the sales was executed pursuant to a 10b5-1 trading plan adopted on 06/05/2025, and the filer states the sales served to cover tax liabilities from released restricted stock units.

Insider sale to cover taxes by Arteris CFO. On 10/02/2025, Nicholas B. Hawkins, the company’s Vice President and Chief Financial Officer, reported three open-market sales of 3,887 shares of Arteris, Inc. (AIP) at an effective price of $10.9208 per share. The three disposals were for 891, 1,508 and 1,488 shares and reduced the reporting person’s direct holdings in stages from 103,007 shares to 100,011 shares following the transactions.

The filing states the shares were sold to satisfy the reporting person’s tax liability triggered by the release of restricted stock units. The Form 4 was signed by an attorney-in-fact on 10/06/2025. No derivative transactions or other types of securities were reported.